MediciNova, Inc.
MNOV · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -8.4% | – | – | – |
| Gross Profit | -$0 | $0 | $0 | -$0 |
| % Margin | -31.6% | 13.6% | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,435.4% | -2,676.1% | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,473.6% | -2,437.7% | – | – |
| EPS Diluted | -0.06 | -0.067 | -0.058 | -0.057 |
| % Growth | 10.3% | -14.6% | -1.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |